Tag: CDSCO
Novartis Receives European Commission Approval for Itvisma®️ for older patient with spinal muscular atrophy
Novartis announced that the European Commission has approved Itvisma® (onasemnogene abeparvovec) for the treatment of 5q spinal muscular atrophy (SMA) with a bi-allelic mutation...
Yashoda hospitals, Hyderabad: where innovation meets compassionate care
For nearly 30 years, Yashoda hospitals has been more than a name in Hyderabad healthcare landscape- it has been a promise. With four thriving...
Gujarat Charts Course to Become India’s Leading Biotechnology Hub by 2030
A newly released study by the Gujarat Rajya Institute for Transformation (GRIT) has laid out a strategic vision for positioning Gujarat as India's foremost biotechnology and biomanufacturing centre...
Milestone for Indian Medical Heritage: Maharishi Sushruta Bronze Statue Installed in Edinburgh’s Royal College
The Royal College of Surgeons of Edinburgh has permanently installed a 90-kilogram bronze statue of Maharishi Sushruta, universally revered as the “Father of Surgery.” Positioned...
Viatris’ VR-205 Shows Strong Phase 3 Results in Japanese IgA Nephropathy Patients
Viatris Inc. (Nasdaq: VTRS) - reported encouraging top-line data from a Phase 3 trial of VR-205, a targeted-release budesonide therapy marketed elsewhere as Tarpeyo and Kinpeygo, in Japanese adults living...
Shilpa Biologicals Activates GMP-Certified ADC Manufacturing Hub in Dharwad, India
Shilpa Biologicals, the biologics arm of Raichur-based Shilpa Medicare Ltd., has formally activated its antibody–drug conjugate (ADC) drug substance manufacturing facility in Dharwad, India. The plant is currently...